Thus, while inhibition of LMWPTP in both of these colorectal cancer lines appears beneficial in terms of reducing cell growth, drug resistance and metastatic potential, the mechanisms through which this is achieved may rely on genetic identity of the tumor cells. Here, ACP1 is linked to colorectal cancer.